Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sain Medicaments is a leading Indian pharmaceutical formulation and manufacturing company established in 1973. Headquartered in Hyderabad, India, the company specializes in the development, manufacture, and supply of a comprehensive range of branded generic pharmaceutical products, including tablets, capsules, syrups, dry syrups, and suspensions. Its therapeutic portfolio spans diverse areas such as cardiology, psychotropics, hypoglycemic agents, antibiotics, anti-ulcerants, and nutraceuticals. Operating a state-of-the-art, WHO-GMP and ISO 9001 certified manufacturing facility, Sain Medicaments serves both the Indian domestic market and exports to over 27 countries across five continents. The company also acts as a contract manufacturing organization (CMO) for global partners, delivering high-quality, cost-effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAIN.